309
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A review of how psychotropic medication can affect the motivation of challenging behavior

&

References

  • Aman, M. G., Lam, K. S. L. and Collier-Crespin, A. 2003. Prevalence and patterns of use of psychoactive medicines among individual with autism in the autism society of Ohio. Journal of Autism and Developmental Disorders, 33, 527–534.10.1023/A:1025883612879
  • Anderson, M. T., Vu, C., Derby, K. Mark, Goris, M. and McLaughlin, T. F. 2002. Using functional analysis procedures to monitor medication effects in an outpatient and school setting. Psychology in the Schools, 39, 73–76. doi:10.1002/pits.10006.
  • Beavers, G., Iwata, B. A. and Lerman, D. C. 2013. Thirty years of research on the functional analysis of problem behavior. Journal of Applied Behavior Analysis, 46, 1–21. doi:10.1002/jaba.30.
  • Berg, W. K., Peck, S., Wacker, D. P., Harding, J., McComas, J., Richman, D. and Brown, K. 2000. The effects of presession exposure to attention on the results of assessments of attention as a reinforcer. Journal of Applied Behavior Analysis, 33, 463–477. doi:10.1901/jaba.2000.33-463.
  • Canadian Pharmacists Association. 2013. Compendium of pharmaceuticals and specialties, [ online (e-CPS)]. Available at: https://www-e-therapeuticsca.proxy.library.brocku.ca/cps.showMonograph.action [Accessed 10 April 2015].
  • Carrick, R., Mitchell, A., Powell, R. A. and Lloyd, K. 2004. The quest for well-being: A qualitative study of the experience of taking antipsychotic medication. Psychology and Psychotherapy: Theory, Research and Practice, 77, 19–33. doi:10.1348/147608304322874236.
  • Couppis, M. H. and Kennedy, C. H. 2008. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology, 197, 449–456. doi:10.1007/s00213-007-1054-y.
  • Cox, A. and Virues-Ortega, J. 2016. Interactions between behavior function and exposure to psychotropic medication. Journal of Applied Behavior Analysis, 49, 84–104. doi:10.1002/jaba.247.
  • Crosland, K. A., Zarcone, J. R., Lindauer, S. E., Valdovinos, M. G., Zarcone, T. J., Hellings, J. A. and Schroeder, S. R. 2003. Use of a functional analysis methodology in the evaluation of medication effects. Journal of Autism and Developmental Disorders, 33, 271–279. doi:10.1023/A:1024402500425.
  • Danov, S. E., Tervo, R., Meyers, S. and Symons, F. J. 2012. Using functional analysis methodology to evaluate the effects of an atypical antipsychotic on severe problem behavior. Journal of Mental Health Research, 5, 286–308. doi:10.1080/19315864.2011.594976.
  • Deb, S., Unwin, G. and Deb, T. 2015. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Journal of Intellectual Disability Research, 59, 11–25. doi:10.1111/jir.12119.
  • Edrisinha, C., O’Reilly, M., Sigafoos, J., Lancioni, G. and Choi, H. Y. 2011. Influence of motivating operations and discriminative stimuli on challenging behavior maintained by positive reinforcement. Research in Developmental Disabilities, 32, 836–845. doi:10.1016/j.ridd.2010.10.006.
  • Felce, D., Lowe, K., Bechma, J. and Hallan, A. 2000. Exploring the relationships between costs and quality of services for adults with severe intellectual disabilities and the most severe challenging behaviours in Wales: A multivariate regression analysis. Journal of Intellectual & Developmental Disability, 25, 307–326. doi:10.1080/13668250020019593.
  • Firestone, P. and Marshall, W. L. eds. 2007. Abnormal psychology perspectives. Canada: Prentice Hall Allyn and Bacon.
  • Gagiano, C., Read, S., Thorpe, L., Eerdekens, M. and Van Hove, I. 2005. Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders. Psychopharmacology, 179, 629–636. doi:10.1007/s00213-004-2093-2.
  • Garcia, D. and Smith, R. G. 1999. Using analog baselines to assess the effects of naltrexone on self-injurious behavior11This research was supported in part by a grant from the Texas Higher Education Coordinating Board and is based on a thesis submitted by the first author in partial fulfillment of the requirement for a Master of Science degree. The authors acknowledge the support of the Denton State School and the assistance of Angela Gonzalez and Robert Churchill during the conduct of this study. Research in Developmental Disabilities, 20, 1–21.10.1016/S0891-4222(98)00028-6
  • Grey, I. M. and Hastings, R. P. 2005. Evidence-based practices in intellectual disability and behaviour disorders. Current Opinion in Psychiatry, 18, 469–475. doi:10.1097/01.yco.0000179482.54767.cf.
  • Handen, B. L., Johnson, C. R. and Lubetsky, M. 2000. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. Journal of Autism and Developmental Disorders, 30, 245–255.10.1023/A:1005548619694
  • Hanley, G. P., Jin, S., Vanselow, N. R. and Hanratty, L. A. 2014. Producing meaningful improvements in problem behavior of children with autism via synthesized analyses and treatments. Journal of Applied Behavior Analysis, 47, 16–36. doi:10.1002/jaba.106.
  • Hayes, S. C., Barlow, D. H. and Nelson-Gray, R. O. 1999. The scientist practitioner: Research and accountability in the age of managed care. Boston: Allyn & Bacon.
  • Heyvaert, M., Maes, B. and Onghena, P. 2010. A meta-analysis of intervention effects on challenging behaviour among persons with intellectual disabilities. Journal of Intellectual Disability Research, 54, 634–649. doi:10.1111/j.1365-2788.2010.01291.x.
  • Heyvaert, M., Maes, B., Van den Noortgate, W., Kuppens, S. and Onghena, P. 2012. A multilevel meta-analysis of single-case and small-n research on interventions for reducing challenging behavior in persons with intellectual disabilities. Research in Developmental Disabilities, 33, 766–780. doi:10.1016/j.ridd.2011.10.010.
  • Hill, A. 1965. The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58, 295–300.
  • Hollander, E., Soorya, L., Chaplin, W., Anagnostou, E., Ferretti, C. J., Wasserman, S.¸ Swanson, E. and Settipani, C. 2012. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. American Journal of Psychiatry, 169, 292–299. doi:10.1176/appi.ajp.2011.10050764.
  • Iwata, B. A., Dorsey, M. F., Slifer, K. J., Bauman, K. E. and Richman, S. G. 1994. Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis, 27, 197–209. doi:10.1901/jaba.1994.27-197 (original published 1982)
  • Julien, E. M. 1995. A primer of medication action: A concise, non-technical guide to the actions, uses, and side effects of psychoactive medications. 7th ed. New York, NY: W. H. Freeman and Company.
  • Kennedy, C. H. and Meyer, K. A. 1996. Sleep deprivation, allergy symptoms, and negatively reinforced problem behavior. Journal of Applied Behavior Analysis, 29, 133–135. doi:10.1901/jaba.1996.29-133.
  • Kodak, T., Grow, L. and Northup, J. 2004. Functional analysis and treatment of elopement for a child with attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis, 37, 229–232. doi:10.1901/jaba.2004.37-229.
  • Larsen, E. B. and Gerlach, J. 1996. Subjective experience of treatment, side effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica, 93, 381–388.10.1111/acp.1996.93.issue-5
  • LaRue, R. H., Northup, J., Baumeister, A. A., Hawkins, M. F., Seale, L., Williams, T. and Ridgway, A. 2008. An evaluation of stimulant medication on the reinforcing effects of play. Journal of Applied Behavior Analysis, 41, 143–147. doi:10.1901/jaba.2008.41-143.
  • Lerman, D. and Iwata, B. A. 1996. A methodology for distinguishing between extinction and punishment effects associated with response blocking. Journal of Applied Behavior Analysis, 29, 231–233. doi:10.1901/jaba.1996.29-231.
  • Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., Tager-Flusberg, H. and Lainhart, J. E. 2006. Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36, 861. doi:10.1007/s10803-006-0123-0.
  • Lord, C. and Paul, R. 1997. Language and communication in autism. In D. J. Cohen and F. R. Volkmar eds., Handbook of autism and pervasive developmental disorders 2nd ed. New York, NY: Wiley, pp. 95–225.
  • McDougle, C. J., Kresch, L. E., Goodman, W. K., Naylor, S. T., Volkmar, F. R., Cohen, D. J. and Price, L. H. 1995. A case controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 152, 772–777.
  • Michael, J. 1982. Distinguishing between discriminative and motivational functions of stimuli. Journal of the Experimental Analysis of Behavior, 37, 149–155.10.1901/jeab.1982.37-149
  • Miral, S., Gencer, O., Inal-Emiroglu, F., Baykara, B., Baykara, A. and Dirik, E. 2008. Risperidone versus haloperidol in children and adolescents with AD. European Child and Adolescent Psychiatry, 17, 1–8. doi:10.1007/s00787-007-0620-5.
  • Moore, T. P., Tervo, R. C., McComas, J. J. and Rivard, P. F. 2009. Longitudinal functional analysis of problem behavior during an atypical neuroleptic medication cross-over evaluation for an adolescent with developmental disabilities. Education and Treatment of Children, 32, 105–119. doi:10.1353/etc.0.0042.
  • Myers, S. M. 2007. The status of pharmacotherapy for autism spectrum disorders. Expert Opinion Pharmacotherapy, 8, 1603. doi:10.1517/14656566.8.11.1579.
  • Myrbakk, E. and Von Tetzchner, S. 2008. The prevalence of behavior problems among people with intellectual disability living in community settings. Journal of Mental Health Research in Intellectual Disabilities, 1, 205–222. doi:10.1080/19315860802115607.
  • Newton, T. F., Ling, W., Kalechstein, A. D., Uslaner, J. and Tervo, K. 2001. Risperidone pre- treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Research, 102, 227–233. doi:10.1016/S0165-1781(01)00255-4.
  • Northup, J., Fusilier, I., Swanson, V., Huete, J., Bruce, T., Freeland, J., Gulley, V. and Edwards, S. 1999. Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. Journal of Applied Behavior Analysis, 32, 35–50. doi:10.1901/jaba.1999.32-35.
  • Northup, J., Jones, K., Broussard, C., DiGiovanni, G., Herring, M., Fusilier, I. and Hanchey, A. 1997. A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate. Journal of Applied Behavior Analysis, 30, 121–125. doi:10.1901/jaba.1997.30-121.
  • O’Reilly, M. F. and Lancioni, G. 2000. Response covariation of escape-maintained aberrant behavior correlated with sleep deprivation. Research in Developmental Disabilities, 21, 125–136. doi:10.1016/S0891-4222(00)00029-9.
  • O’Reilly, M. F. 1995. Functional analysis and treatment of escape-maintained aggression correlated with sleep deprivation. Journal of Applied Behavior Analysis, 28, 225–226. doi:10.1901/jaba.1995.28-225.
  • O’Reilly, M. F. 1997. Functional analysis of episodic self-injury correlated with recurrent otitis media. Journal of Applied Behavior Analysis, 30, 165–167. doi:10.1901/jaba.1997.30-165.
  • Qureshi, H. and Alborz, A. 1992. Epidemiology of challenging behaviour. Mental Handicap Research, 5, 130–145. doi:10.1111/j.1468-3148.1992.tb00041.x.
  • Richman, D. M. and Hagopian, L. P. 1999. On the effects of “quality” of attention in the functional analysis of destructive behavior. Research in Developmental Disabilities, 20, 51–62. doi:10.1016/S0891-4222(98)00031-6.
  • Schlichenmeyer, K. L., Roscoe, E. M., Rooker, G. W., Wheeler, E. E. and Dube, W. W. 2013. Idiosyncratic variables that affect functional analysis outcomes: A review (2001–2010). Journal of Applied Behavior Analysis, 46, 339–348. doi:10.1002/jaba.12.
  • Sheehan, R., Hassiotis, A., Walters, K., Osborn, D., Strydom, A. and Horsfall, L. 2015. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. British Medical Journal, 351, h4326–4334. doi:10.1136/bmj.h4326.
  • Sidman, M. 1960. Tactics of scientific research: Evaluating experimental data in psychology. New York, NY: Basic Books.
  • Smith, R., Russo, L and Le, D. 1999. Distinguishing between extinction and punishment effects of response blocking: A replication. Journal of Applied Behavior Analysis, 32, 367–370. doi:10.1901/jaba.1999.32-367.
  • Sy, J. R. and Borrero, J. C. 2009. Parametric analysis of presession exposure to edible and nonedible stimuli. Journal of Applied Behavior Analysis, 42, 833–837. doi:10.1901/jaba.2009.42-833.
  • Thomason-Sassi, J. L., Iwata, B. A., Neidert, P. L. and Roscoe, E. M. 2011. Response latency as an index of response strength during functional analyses of problem behavior. Journal of Applied Behavior Analysis, 44, 51–67. doi:10.1901/jaba.2011.44-51.
  • Tiger, J. H., Hanley, G. P. and Bessette, K. K. 2006. Incorporating descriptive assessment results into the design of a functional analysis: A case example involving a preschooler’s hand mouthing. Education and Treatment of Children, 29, 107–124.
  • Tsiouris, J. A., Kim, S.-Y., Brown, W. T., Pettinger, J. and Cohen, I. L. 2013. Prevalence of psychotropic medication use in adults with intellectual disability: Positive and negative findings from a large scale study. Journal of Autism and Developmental Disorders, 43, 419–431. doi:10.1007/s10803-012-1617-6.
  • Valdovinos, M. G., Ellringer, N. P. and Alexander, M. L. 2007. Changes in the rate of problem behaviour with the discontinuation of the antipsychotic medication quetiapine. Mental Health Aspects of Developmental Disabilities, 10, 64–67.
  • Valdovinos, M. G., Nelson, S. M., Kuhle, J. L. and Dierks, A. M. 2009. Using analogue functional analysis to measure variations in problem behavior rate and function after psychotropic medication changes: A clinical demonstration. Journal of Mental Health Research in Intellectual Disabilities, 2, 279–293. doi:10.1080/19315860903104807.
  • Wallace, M. D. and Iwata, B. A. 1999. Effects of session duration on functional analysis outcomes. Journal of Applied Behavior Analysis, 32, 175–183.10.1901/jaba.1999.32-175
  • Ward, A. C. 2009. The role of causal criteria in causal inferences: Bradford Hill’s “aspects of association”. Epidemiologic Perspectives & Innovations, 6, 1–22. doi:10.1186/1742-5573-6-2.
  • Zarcone, J. R., Lindauer, S. E., Morse, P. S., Crosland, K. A., Valdovinos, M. G., McKerchar, T. L., Reese, M. R., Hellings, J. A. and Schroeder, S. R. 2004. Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. American Journal on Mental Retardation, 109, 310–321. doi:10.1352/0895-8017(2004)109%3C310:EORODB%3E2.0.CO;2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.